VITAMIN D AND BRONCHIAL INFLAMMATION IN ASTHMATIC CHILDREN

M Miraglia Del Giudice1, A Allegorico1, A Grandone1

  • 1Department of Women, Child and General and Special Surgery, Second University of Naples, Italy.

Insights

Vitamin D plays a crucial role in reducing bronchial inflammation. Higher vitamin D levels in children correlate with lower fractional exhaled nitric oxide, indicating better asthma control.

Area of Science:

  • Endocrinology
  • Immunology
  • Pulmonology

Background:

  • Vitamin D is traditionally known for calcium homeostasis and bone metabolism.
  • Emerging research highlights vitamin D's role in host defense, inflammation, and immunity.
  • Low vitamin D levels are linked to impaired lung function and increased risk of inflammatory and infectious diseases.

Purpose of the Study:

  • To investigate the correlation between vitamin D levels and allergic inflammation.
  • To assess the impact of vitamin D on lung function and asthma control in children.

Main Methods:

  • Studied the relationship between serum vitamin D levels and fractional exhaled nitric oxide (FeNO).
  • Analyzed FeNO values in children with varying vitamin D levels.

Main Results:

  • A significant decrease in FeNO values was observed in children with vitamin D levels greater than 30 ng/ml (p=0.0018).
  • This suggests a positive correlation between adequate vitamin D levels and reduced bronchial inflammation.

Conclusions:

  • Vitamin D significantly influences bronchial inflammation.
  • Maintaining sufficient vitamin D levels may be beneficial for managing asthma and improving lung health in children.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K